Electron News and Research

RSS

Study identifies broad-spectrum antibody that neutralizes SARS-CoV-2 variants of concern

Scientists have described the identification and therapeutic evaluation of an antibody that broadly neutralizes major variants of SARS-CoV-2, including the alpha, beta, delta, and omicron variants.

5 Aug 2022

KAIST researchers engineer a bacterial strain capable of producing lutein

A research group at KAIST has engineered a bacterial strain capable of producing lutein. The research team applied systems metabolic engineering strategies, including substrate channeling and electron channeling, to enhance the production of lutein in an engineered Escherichia coli strain.

4 Aug 2022

Polymer-embedded copper-based nanoparticles prevent surface contamination by viruses

In a new study, researchers developed nanocomposite coatings to prevent surface contamination by a human coronavirus (HCoV).

4 Aug 2022

Researchers unravel mechanism of action of bacterial Tc toxin in fatal attacks

A harmful and often deadly substance made by bacteria, a bacterial toxin manipulates host cell functions and disrupts vital cell processes in a living organism.

3 Aug 2022

Study defines how cannabis cells make cannabinoids

For the first time, plant biologists have defined the high-efficiency "hacks" that cannabis cells use to make cannabinoids (THC/CBD). Although many biotechnology companies are currently trying to engineer THC/CBD outside the plant in yeast or cell cultures, it is largely unknown how the plant does it naturally.

3 Aug 2022

Jianhua Zhao secures $2.4 million NIGMS grant to study the molecular machinery of proteolysis

Assistant Professor Jianhua Zhao, Ph.D., has been awarded a unique and competitive grant from the National Institute of General Medical Sciences, part of the National Institutes of Health.

2 Aug 2022

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

2 Aug 2022

Symptoms of monkeypox differ from previous outbreaks

A new study describes the clinical characteristics of monkeypox infections during the current outbreak.

1 Aug 2022

NIH updates its strategic plan for hepatitis B research

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care.

1 Aug 2022

Würzburg scientists are working on the development of new drugs to combat monkeypox

Poxviruses pose a threat to humanity that should be taken seriously, as the current outbreak of monkeypox shows.

1 Aug 2022

$Synchrotron X-ray diffraction can aid in the diagnosis of invisible traumatic brain injuries$

Synchrotron X-ray diffraction can aid in the diagnosis of invisible traumatic brain injuries

Traumatic brain injuries (TBIs) are usually diagnosed with MRI and computed tomography scans, but these techniques often miss more mild damage.

31 Jul 2022

Researchers report near-atomic-resolution images of nitrogenase during catalysis using cryo-EM

Previously, it has been impossible to capture the high-resolution images of nitrogenase, the only enzyme capable of reducing nitrogen into ammonia, during catalytic action.

29 Jul 2022

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

A recent study published in Nature Microbiology identified a monoclonal antibody neutralizing SARS-CoV-2 Omicron variants.

28 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

An enzyme may be a potent new tool for reducing nitrous oxide in the atmosphere

An enzyme that combats the greenhouse gas nitrous oxide (N2O) may one day give scientists a potent new tool for reducing the amount of the gas in the atmosphere thanks in part to new findings published today in Nature.

28 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

Tunneling nanotubes can assist SARS-CoV-2 propagation

A new study found that tunneling nanotubes (TNTs) offer a pathway for SARS-CoV-2 neuronal spreading.

26 Jul 2022

SARS-CoV-2 hijacks tiny bridges that link infected cells with neurons to gain access to brain cells

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both during the acute phase of the disease and over the long term with "long COVID" syndrome.

25 Jul 2022

Improving the immune defenses against blood cancer

For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen receptor T cells (CAR T cells) is sometimes the last chance of overcoming the cancer.

22 Jul 2022

Unlocking the power of proteins to better understand human health

We speak to Andrew Lynn, the chief executive at Fluidic Analytics, about the role proteins play in understanding human disease.

From Fluidic Analytics 21 Jul 2022

Electron News and Research

Study identifies broad-spectrum antibody that neutralizes SARS-CoV-2 variants of concern

KAIST researchers engineer a bacterial strain capable of producing lutein

Polymer-embedded copper-based nanoparticles prevent surface contamination by viruses

Researchers unravel mechanism of action of bacterial Tc toxin in fatal attacks

Study defines how cannabis cells make cannabinoids

Jianhua Zhao secures $2.4 million NIGMS grant to study the molecular machinery of proteolysis

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Symptoms of monkeypox differ from previous outbreaks

NIH updates its strategic plan for hepatitis B research

Würzburg scientists are working on the development of new drugs to combat monkeypox

Synchrotron X-ray diffraction can aid in the diagnosis of invisible traumatic brain injuries

Researchers report near-atomic-resolution images of nitrogenase during catalysis using cryo-EM

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

Mesoporous silica nanoparticles: Possibilities in therapeutic development

An enzyme may be a potent new tool for reducing nitrous oxide in the atmosphere

Innovative technology reveals new insights into cellular reservoirs of HIV

Tunneling nanotubes can assist SARS-CoV-2 propagation

SARS-CoV-2 hijacks tiny bridges that link infected cells with neurons to gain access to brain cells

Improving the immune defenses against blood cancer

Unlocking the power of proteins to better understand human health

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News